HNRNPR expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.00090047361334E-10 |
Normal-vs-Stage2 |
2.835600E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
8.990800E-04 |
Stage1-vs-Stage2 |
7.393200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
6.402600E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
5.729600E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.6621374255883E-15 |
Normal-vs-AfricanAmerican |
5.255700E-02 |
Normal-vs-Asian |
1.290290E-02 |
Caucasian-vs-AfricanAmerican |
3.430100E-02 |
Caucasian-vs-Asian |
8.337200E-01 |
AfricanAmerican-vs-Asian |
4.566200E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.910699999914E-07 |
Normal-vs-Female |
7.71127606213895E-12 |
Male-vs-Female |
3.015200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.185630E-04 |
Normal-vs-Extreme_Weight |
1.66189999539768E-08 |
Normal-vs-Obese |
1.174020E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
2.079400E-01 |
Normal_Weight-vs-Obese |
5.254200E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
2.939400E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.04799999789407E-08 |
Normal-vs-Age(41-60Yrs) |
4.57139999998635E-06 |
Normal-vs-Age(61-80Yrs) |
9.47386613603385E-12 |
Normal-vs-Age(81-100Yrs) |
4.986200E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.765600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.216000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.453800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.974000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.887240E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.097900E-02 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
9.146600E-01 |
Normal-vs-Grade 3 |
8.301600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
3.660200E-01 |
Grade 2-vs-Grade 4 |
9.146600E-01 |
Grade 3-vs-Grade 4 |
8.301600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.21884749357559E-13 |
Normal-vs-N1 |
2.207600E-04 |
N0-vs-N1 |
3.561700E-02 |
|
|